- Report
- October 2023
- 78 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- May 2023
- 77 Pages
Global
From €3500EUR$3,901USD£3,106GBP
- Report
- March 2024
- 132 Pages
Global
From €913EUR$950USD£783GBP
- Report
- February 2024
- 132 Pages
Global
From €913EUR$950USD£783GBP
- Report
- February 2018
- 78 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- March 2020
- 112 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Report
- June 2023
- 236 Pages
Global
From €5507EUR$5,730USD£4,723GBP
- Report
- December 2021
- 290 Pages
Global
From €5928EUR$6,168USD£5,084GBP
- Report
- July 2023
- 160 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Report
- May 2023
- 147 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Report
- March 2022
- 234 Pages
Global
From €5545EUR$5,769USD£4,755GBP
- Report
- September 2019
Global
From €5161EUR$5,370USD£4,426GBP
- Report
- May 2023
- 147 Pages
Global
From €5766EUR$5,999USD£4,945GBP
- Book
- February 2023
- 576 Pages
- Book
- December 2019
- 312 Pages
- Book
- March 2013
- 536 Pages
- Book
- January 2015
- 360 Pages
The Capsule Drug Delivery market is a subset of the pharmaceutical industry that focuses on the development and manufacture of capsules for the delivery of drugs. Capsules are a form of drug delivery that can be used to deliver a variety of drugs, including oral, topical, and injectable medications. Capsules are designed to provide a controlled release of the drug, allowing for a more consistent and predictable delivery of the medication. Capsules can also be used to improve the bioavailability of drugs, as well as to reduce the side effects associated with certain medications.
The Capsule Drug Delivery market is highly competitive, with a number of companies offering a variety of products and services. Some of the major players in the market include Capsugel, Catalent, Lonza, and Patheon. Other companies in the market include Aenova, CapsCanada, and Qualicaps. Show Less Read more
